Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,258
datasets available to search
ShareScore release 0.9.0
Dataset results
1,258 results for “neuroblastoma”
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT01334515. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
ClinicalTrials.gov study NCT00098865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment
ClinicalTrials.gov study NCT00436852. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
ClinicalTrials.gov study NCT00578864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Syn
ClinicalTrials.gov study NCT02452554. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma
ClinicalTrials.gov study NCT01460901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
ClinicalTrials.gov study NCT00601003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
ClinicalTrials.gov study NCT01798004. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
ClinicalTrials.gov study NCT05429502. IPD Sharing: YES. Countries: 4. Publications: 0.
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
ClinicalTrials.gov study NCT01041638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma
ClinicalTrials.gov study NCT05373901. IPD Sharing: YES. Countries: 1. Publications: 0.
Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma
ClinicalTrials.gov study NCT03061656. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
ClinicalTrials.gov study NCT03015844. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT00698009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
ClinicalTrials.gov study NCT01355679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
ClinicalTrials.gov study NCT04751383. IPD Sharing: YES. Countries: 2. Publications: 0.
Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT02139397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
ClinicalTrials.gov study NCT02043899. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
ClinicalTrials.gov study NCT02693171. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
ClinicalTrials.gov study NCT01483820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.